Botanical drugs and supplements affecting the immune response in the time of COVID‐19: Implications for research and clinical practice

T Brendler, A Al‐Harrasi, R Bauer… - Phytotherapy …, 2021 - Wiley Online Library
In times of health crisis, including the current COVID‐19 pandemic, the potential benefit of
botanical drugs and supplements emerges as a focus of attention, although controversial …

Antimicrobial activity of South African medicinal plants

SF Van Vuuren - Journal of ethnopharmacology, 2008 - Elsevier
This paper reviews the antimicrobial research undertaken on South African medicinal plants
during the period 1997–2008. Antimicrobial methods (disc diffusion, minimum inhibitory …

Pelargonium sidoides extract for treating acute respiratory tract infections

A Timmer, J Günther, E Motschall… - Cochrane Database …, 2013 - cochranelibrary.com
Background Pelargonium sidoides (P. sidoides), also known as Umckaloabo, is a herbal
remedy thought to be effective in the treatment of acute respiratory infections (ARIs) …

The Effect of Pelargonium endlicherianum Fenzl. root extracts on formation of nanoparticles and their antimicrobial activities

GŞ Karatoprak, G Aydin, B Altinsoy… - Enzyme and microbial …, 2017 - Elsevier
Herein, we report the biosynthesis of Ag NPs, for the first time, using identified antimicrobial
molecules (gallic acid+ apocynin) and (gallic acid+ apocynin+ quercetin) from the medicinal …

A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae)

T Brendler, BE Van Wyk - Journal of ethnopharmacology, 2008 - Elsevier
ETHNOPHARMACOLOGICAL CONTEXT: A detailed review of the ethnobotany and
commercial history of Pelargonium sidoides is presented, together with a brief summary of …

EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo

LL Theisen, CP Muller - Antiviral research, 2012 - Elsevier
A prodelphinidin-rich extract from Pelargonium sidoides DC, EPs® 7630 (Umckaloabo®),
which is licensed to treat respiratory tract infections such as acute bronchitis, was …

[HTML][HTML] Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells

J Papies, J Emanuel, N Heinemann, Ž Kulić… - Frontiers in …, 2021 - frontiersin.org
Treatment options for COVID-19 are currently limited. Drugs reducing both viral loads and
SARS-CoV-2-induced inflammatory responses would be ideal candidates for COVID-19 …

[HTML][HTML] Potential of herbal products in prevention and treatment of COVID-19. Literature review

A Gajewski, A Kośmider, A Nowacka, O Puk… - Biomedicine & …, 2021 - Elsevier
The COVID-19 epidemic is the greatest pandemic that human kind experienced for decades,
with high morbidity and mortality. Despite recent development of vaccines there is still many …

Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial

VG Lizogub, DS Riley, M Heger - Explore, 2007 - Elsevier
BACKGROUND: The common cold is a viral infection with symptoms such as sneezing, sore
throat, and running nose. It is one of the most prevalent illnesses in the world, and although …

Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children

D Careddu, A Pettenazzo - International journal of general …, 2018 - Taylor & Francis
Background In numerous randomized controlled trials (RCTs) and systematic reviews such
as those published by the Cochrane Collaboration, Pelargonium sidoides extract EPs® …